Last reviewed · How we verify
Ropivacaine 0.5% 20 mLs
Ropivacaine 0.5% 20 mLs is a Small molecule drug developed by Centre Hospitalier Universitaire Vaudois. It is currently FDA-approved. Also known as: Naropine, Naropin.
At a glance
| Generic name | Ropivacaine 0.5% 20 mLs |
|---|---|
| Also known as | Naropine, Naropin |
| Sponsor | Centre Hospitalier Universitaire Vaudois |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Reducing Pain and Disability After Breast Cancer Surgery (NA)
- Can Single-Injection Adductor Canal Blocks Improve PostOp Pain Relief in Patients Undergoing Total Knee Arthroplasty? (NA)
- Serratus and Parasternal Infrapectoral Block for Breast Surgery. (NA)
- Dexamethasone as an Adjuvant to Ropivacaine for the Interscalene Brachial Plexus Block (PHASE4)
- Local Infiltration Analgesia vs Adductor Canal Block for Analgesia After Anterior Cruciate Ligament Reconstruction (PHASE4)
- Transversus Abdominis Plane (TAP) Block Laparoscopic Hysterectomy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ropivacaine 0.5% 20 mLs CI brief — competitive landscape report
- Ropivacaine 0.5% 20 mLs updates RSS · CI watch RSS
- Centre Hospitalier Universitaire Vaudois portfolio CI
Frequently asked questions about Ropivacaine 0.5% 20 mLs
What is Ropivacaine 0.5% 20 mLs?
Ropivacaine 0.5% 20 mLs is a Small molecule drug developed by Centre Hospitalier Universitaire Vaudois.
Who makes Ropivacaine 0.5% 20 mLs?
Ropivacaine 0.5% 20 mLs is developed and marketed by Centre Hospitalier Universitaire Vaudois (see full Centre Hospitalier Universitaire Vaudois pipeline at /company/centre-hospitalier-universitaire-vaudois).
Is Ropivacaine 0.5% 20 mLs also known as anything else?
Ropivacaine 0.5% 20 mLs is also known as Naropine, Naropin.
What development phase is Ropivacaine 0.5% 20 mLs in?
Ropivacaine 0.5% 20 mLs is FDA-approved (marketed).
Related
- Manufacturer: Centre Hospitalier Universitaire Vaudois — full pipeline
- Also known as: Naropine, Naropin
- Compare: Ropivacaine 0.5% 20 mLs vs similar drugs
- Pricing: Ropivacaine 0.5% 20 mLs cost, discount & access